Fritz H. Schröder

41.2k total citations · 5 hit papers
501 papers, 22.7k citations indexed

About

Fritz H. Schröder is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Fritz H. Schröder has authored 501 papers receiving a total of 22.7k indexed citations (citations by other indexed papers that have themselves been cited), including 436 papers in Pulmonary and Respiratory Medicine, 106 papers in Surgery and 95 papers in Oncology. Recurrent topics in Fritz H. Schröder's work include Prostate Cancer Treatment and Research (355 papers), Prostate Cancer Diagnosis and Treatment (326 papers) and Bladder and Urothelial Cancer Treatments (68 papers). Fritz H. Schröder is often cited by papers focused on Prostate Cancer Treatment and Research (355 papers), Prostate Cancer Diagnosis and Treatment (326 papers) and Bladder and Urothelial Cancer Treatments (68 papers). Fritz H. Schröder collaborates with scholars based in Netherlands, United States and Belgium. Fritz H. Schröder's co-authors include Monique J. Roobol, Theodorus van der Kwast, Chris H. Bangma, Ries Kranse, Harry J. de Koning, Wim J. Kirkels, Roderick C.N. van den Bergh, Tineke Wolters, G.J. van Steenbrugge and André N. Vis and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Fritz H. Schröder

488 papers receiving 21.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate cancer

2015 708 citations Fritz H. Schröder et al. The Lancet profile →
The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer

2008 447 citations Fritz H. Schröder et al. British Journal of Urology profile →
Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

2012 411 citations Fritz H. Schröder, Chris H. Bangma et al. European Urology profile →
Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies

2014 395 citations Fritz H. Schröder et al. European Urology profile →
The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation

2011 346 citations Fritz H. Schröder et al. European Urology profile →

Peers

Countries citing papers authored by Fritz H. Schröder

Since Specialization

Citations

This map shows the geographic impact of Fritz H. Schröder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fritz H. Schröder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fritz H. Schröder more than expected).

Fields of papers citing papers by Fritz H. Schröder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fritz H. Schröder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fritz H. Schröder. The network helps show where Fritz H. Schröder may publish in the future.

Co-authorship network of co-authors of Fritz H. Schröder

This figure shows the co-authorship network connecting the top 25 collaborators of Fritz H. Schröder. A scholar is included among the top collaborators of Fritz H. Schröder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fritz H. Schröder. Fritz H. Schröder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men 2013 ·The Aging Male ·Raymond C. Rosen, Frederick C. W. Wu, Hermann M. Behre, Claus G. Roehrborn, Fritz H. Schröder, Flora S. Siami, Julia Martha, Joseph D. Finn, Andre B. Araujo	10
2	Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer 2013 ·European Urology ·Monique J. Roobol, Ries Kranse, Chris H. Bangma, (unknown), B. G. Blijenberg, Ron H. N. van Schaik, Wim J. Kirkels, Suzie J. Otto, Theodorus van der Kwast, Harry J. de Koning, Fritz H. Schröder	91
3	Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate Cancer 2010 ·Cancer Research ·Johannes Hofland, Wytske M. van Weerden, Natasja F. Dits, Jacobie Steenbergen, Geert J.L.H. van Leenders, Guido Jenster, Fritz H. Schröder, Frank H. de Jong	145
4	A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam 2010 ·Clinical Cancer Research ·Andrew J. Vickers, Angel M. Cronin, Monique J. Roobol, Caroline Savage, Mari Peltola, Kim Pettersson, Peter T. Scardino, Fritz H. Schröder, Hans Lilja	95
5	Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication 2010 ·Journal of Clinical Oncology ·Andrew J. Vickers, Angel M. Cronin, Monique J. Roobol, Caroline Savage, Mari Peltola, Kim Pettersson, Peter T. Scardino, Fritz H. Schröder, Hans Lilja	167
6	Sexual and prostate health in a longitudinal, European cohort study: The Registry of Hypogonadism in Men (RHYME). 2010 ·Andrology ·RC Rosen, (unknown), (unknown), Behre Hm, (unknown), (unknown), Fritz H. Schröder, (unknown), Mario Maggi, (unknown), (unknown), (unknown)	1
7	The value of EZH2, p27 ^kip1 , BMI‐1 and MIB‐1 on biopsy specimens with low‐risk prostate cancer in selecting men with significant prostate cancer at prostatectomy 2009 ·British Journal of Urology ·Tineke Wolters, Kees J. Vissers, Chris H. Bangma, Fritz H. Schröder, Geert J.L.H. van Leenders	26
8	POD-11.02: Early Versus Delayed Endocrine Treatment of T2-T3 pN1-3 M0 Prostate Cancer Without Local Treatment of the Primary Tumour: Final Results of European Organisation for the Research and Treatment of Cancer Protocol 30846 After 13 Years of Follow-up 2009 ·Urology ·K. H. Kurth, Fritz H. Schröder, Sophie D. Fosså, (unknown), (unknown), (unknown), (unknown)	5
9	The effect of study arm on prostate cancer treatment in the large screening trial ERSPC 2009 ·International Journal of Cancer ·Tineke Wolters, Monique J. Roobol, Ewout W. Steyerberg, Roderick C.N. van den Bergh, Chris H. Bangma, Jonas Hugosson, Stefano Ciatto, Maciej Kwiatkowski, Arnauld Villers, M. Luján, Vera Nelen, Teuvo L.J. Tammela, Fritz H. Schröder	51
10	High‐resolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancer 2005 ·Genes Chromosomes and Cancer ·Mark van Duin, Ronald van Marion, Kees J. Vissers, J. E. Vivienne Watson, Wytske M. van Weerden, Fritz H. Schröder, Wim C.J. Hop, Theodorus van der Kwast, Colin C. Collins, Herman van Dekken	78
11	Prevalence and characteristics of screen‐detected prostate carcinomas at low prostate‐specific antigen levels: aggressive or insignificant? 2005 ·British Journal of Urology ·Claartje Gosselaar, Monique J. Roobol, Fritz H. Schröder	45
12	Screening for prostate cancer 2003 ·Urologic Clinics of North America ·Fritz H. Schröder	16
13	Renal, bladder, prostate and testicular cancer : an update : the proceedings of the VI Congress on Progress and Controversies in Oncological Urology (PACIOU VI), held in Rotterdam, the Netherlands, October 2000 2001 ·(unknown), (unknown), Karl H. Kurth, G. Mickisch, Fritz H. Schröder	2
14	A phase II study of temozolomide in hormone-refractory prostate cancer 2000 ·Cancer Chemotherapy and Pharmacology ·J.P. van Brussel, Martijn B. Busstra, Margreet Lang, (unknown), Fritz H. Schröder, G. Mickisch	26
15	Antiandrogens as Monotherapy for Prostate Cancer 1998 ·European Urology ·Fritz H. Schröder	25
16	Recent advances in prostate cancer and BPH : the proceedings of the IV Congress on Progress and Controversies in Oncological Urology (PACIOU IV), held in Rotterdam, the Netherlands, April 1996 1997 ·(unknown), (unknown), Fritz H. Schröder	2
17	ANTI-ANDROGENS IN TREATMENT OF PROSTATE-CANCER - REPLY 1995 ·The Lancet ·Otilia Dalesio, R Peto, Fritz H. Schröder	2
18	MAXIMUM ANDROGEN BLOCKADE IN ADVANCED PROSTATE-CANCER - AN OVERVIEW OF 22 RANDOMIZED TRIALS WITH 3283 DEATHS IN 5710 PATIENTS 1995 ·The Lancet ·Otilia Dalesio, (unknown), L. Denis, Fritz H. Schröder, Brent A. Blumenstein, Jon Godwin, R Peto	195
19	Screening, early detection, and treatment of prostate cancer: A European view 1995 ·Urology ·Fritz H. Schröder	25
20	Metastatic potential of human renal cell carcinoma: experimental model using subrenal capsule implantation in athymic nude mice 1992 ·Urological Research ·(unknown), Xiaoxian Zhao, J.C. Romijn, F.J.W. ten Kate, Fritz H. Schröder	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact